CD8A and neoplasm: Inhibition of sestrins, which activate AMPK, could also reduce effector T cell senescence, but could equally be detrimental because sestrins promote senescent-like CD8+ T cells to adopt an NK cell-like phenotype, which could be beneficial in tumor clearance [139].